The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Co-morbidity and Drug Abuse. In Report to the EMCDDA by the Reitox National

På svenska

Author

  • Mats Fridell

Summary, in English

The chapter by definition focuses on Swedish research and treatment practice in the area of comorbiditity. Three “ethiological” lines of comorbidity is outlined. it thus seems warranted to look upon patients with a precipitating psychiatric diagnosis and a consequent problem of alcohol and/or substance abuse as one specific model/type (1). A second type representting the drug and substance dependent person who´s psychiatric and psychological problems often remain unattended until a more thorough assessment is made. Here, personality disorders are by far the most common disorder. Model 3, finally, corresponds to a number of alcohol- and substance dependent persons who are not afflicted by any particular chronical psychiatric or psychological problem despite the severity of the alcohol/substance problem. The reason for differentiating specific comorbid patterns are, apart from diagnostic utility, also the need to gauge treatment carefully. The immediate ways of approaching the patient in a treatment encounter as well as for choosing an adequate treatment intervention differ and contain different possible combinations of psychosocial and pharmacological interventions. The national records of the Swedish National Board of Health and Welfare underreport systematically due to the fact the diagnostic procedures is lacking in clinical treatment and diagnoses consequently reported scarcely. The situations within the hospital system, in prisons and other treatment settings are presented, leaving a clear picture of a heavily afflicted group of patients, where their psychiatric ailments are only dealt with in a few clinics. In drug dependent individuals (type 2), personality disorders are be far the most common problem ranging from 60–85% in clinical settings.

Publishing year

2004

Language

English

Pages

87-128

Publication/Series

2003 to the EMCDDA by the Reitox National Focal Point. Sweden – Drug Situation 2002

Volume

R2004:25

Document type

Book chapter

Publisher

National Institute of Public Health, Sweden

Topic

  • Psychology

Status

Published

ISBN/ISSN/Other

  • ISBN: 91-7257-283-3